This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Laurus Labs Private Limited. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Venkata Ramakrishna Murthy Moturu: Innovator in Pharmaceutical Processes
Introduction
Venkata Ramakrishna Murthy Moturu is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of macitentan, a medication used for treating pulmonary arterial hypertension. His innovative approach has led to the development of a patented process that enhances the efficiency and purity of this important drug.
Latest Patents
Venkata Ramakrishna Murthy Moturu holds a patent for the "Process for the preparation of macitentan." This invention relates to an improved method for synthesizing macitentan and its pharmaceutical acceptable salts. Additionally, the patent includes the development of methylene chloride solvate of macitentan, which plays a crucial role in the preparation of pure macitentan.
Career Highlights
Currently, Venkata Ramakrishna Murthy Moturu is associated with Laurus Labs Private Limited, a prominent company in the pharmaceutical sector. His work at Laurus Labs has allowed him to focus on innovative processes that contribute to the advancement of drug development and production.
Collaborations
Throughout his career, Venkata Ramakrishna Murthy Moturu has collaborated with talented professionals, including Srivardhana Rao Jamjanam and Venkata Sunil Kumar Indukuri. These collaborations have fostered a creative environment that encourages the exchange of ideas and expertise in pharmaceutical innovations.
Conclusion
Venkata Ramakrishna Murthy Moturu is a distinguished inventor whose work in the preparation of macitentan has made a significant impact in the pharmaceutical industry. His dedication to innovation and collaboration continues to drive advancements in drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
